OncoBone Ventures attends AACR-NCI-EORTC oncology scientific event in Boston, MA, during October 11-15 and presents a poster titled: ‘Preclinical Bone Metastasis Technology Platform – Predictive evaluation of Experimental Therapies on Bone Metastasis’.
The Preclinical Bone Metastasis Technology Platform is a key in drug development activities of OncoBone Ventures that will be utilized to evaluate effects of pipeline therapeutic assets on bone metastases.
If you are interested to learn more, please visit the poster A007 on October 12 at 12:30 – 4:00 pm at the event or reach out via https://www.oncobonetherapeutics.com/contact-us/.